Showing results (41-50 of 60) with videos related to
Sort By:
Pageof 6
Expert Opinion on Therapeutic Targets|September 16, 2014
Targeting tumor invasion: the roles of MDA-9/SynteninTimothy P Kegelman, Swadesh K Das, Luni Emdad, et al.Cancer Research|June 3, 2015
Pancreatic Cancer Combination Therapy Using a BH3 Mimetic and a Synthetic TetracyclineBridget A Quinn, Rupesh Dash, Siddik Sarkar, et al.Molecular Cancer Therapeutics|August 19, 2010
Urokinase plasminogen activator receptor and/or matrix metalloproteinase-9 inhibition induces apoptosis signaling through lipid rafts in glioblastoma xenograft cellsChandramu Chetty, Sajani S Lakka, Praveen Bhoopathi, et al.Molecular Systems Biology|October 10, 2023
CellNeighborEX: deciphering neighbor-dependent gene expression from spatial transcriptomics dataHyobin Kim, Amit Kumar, Cecilia Lövkvist, et al.Frontiers in Oncology|April 11, 2022
Enhanced Cancer Therapy Using an Engineered Designer Cytokine Alone and in Combination With an Immune Checkpoint InhibitorAnjan K Pradhan, Praveen Bhoopathi, Santanu Maji, et al.Journal for Immunotherapy of Cancer|June 23, 2025
Novel fusion superkine, IL-24S/IL-15, enhances immunotherapy of brain cancerAmit Kumar, Praveen Bhoopathi, Padmanabhan Mannangatti, et al.Journal of Virology|January 7, 2014
Enterovirus 2Apro targets MDA5 and MAVS in infected cellsQian Feng, Martijn A Langereis, Marie Lork, et al.Proceedings of the National Academy of Sciences of the United States of America|May 16, 2018
MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cellsSarmistha Talukdar, Anjan K Pradhan, Praveen Bhoopathi, et al.Cancers|March 25, 2022
Conversion of a Non-Cancer-Selective Promoter into a Cancer-Selective PromoterPraveen Bhoopathi, Anjan K Pradhan, Amit Kumar, et al.Oncotarget|June 25, 2016
Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasisSwadesh K Das, Chunqing Guo, Anjan K Pradhan, et al.Pageof 6